论文部分内容阅读
目的阐述临床药师参与1例经皮冠状动脉介入术后2个月出现支架内血栓患者治疗的体会及药学监护过程。方法对病例中治疗方案、支架内血栓的可能原因进行分析评价,总结临床药师在药学监护中的价值。结果临床药师通过优化治疗方案和实施细致的药学监护,患者好转出院。半年后回访患者无支架内再狭窄的发生。结论对于支架内再次形成血栓的患者不可忽视基因抵抗的可能性。临床药师应注意监测患者在用药期间可能发生的不良反应,结合患者的病情,协同医师为临床提供优化的治疗方案。
Objective To describe the experiences of clinical pharmacists participating in the treatment of stent thrombosis 2 months after percutaneous transluminal coronary angioplasty and the process of pharmacological monitoring. Methods To analyze and evaluate the treatment regimen and the possible causes of stent thrombosis, and to summarize the value of clinical pharmacists in pharmacy care. Results The clinical pharmacist discharged and discharged the patients by optimizing the treatment plan and implementing meticulous care. Six months after the visit without stent restenosis. Conclusion The possibility of gene resistance should not be overlooked in patients with thrombus formation within the stent again. Clinical pharmacists should pay attention to monitoring patients during the medication may occur adverse reactions, combined with the patient’s condition, collaborative physicians for the clinical to provide optimal treatment.